92 related articles for article (PubMed ID: 28361526)
1. Ceftolozane-tazobactam for the treatment of ventilator-associated infections by colistin-resistant Pseudomonas aeruginosa.
Álvarez Lerma F; Muñoz Bermudez R; Grau S; Gracia Arnillas MP; Sorli L; Recasens L; Mico García M
Rev Esp Quimioter; 2017 Jun; 30(3):224-228. PubMed ID: 28361526
[TBL] [Abstract][Full Text] [Related]
2. Treatment of multidrug-resistant Pseudomonas aeruginosa bacteremia using ceftolozane-tazobactam-based or colistin-based antibiotic regimens: A multicenter retrospective study.
Hakeam HA; Askar G; Al Sulaiman K; Mansour R; Al Qahtani MM; Abbara D; Aldhayyan N; Dyab N; Afaneh L; Islami M; Al Duhailib Z
J Infect Public Health; 2022 Oct; 15(10):1081-1088. PubMed ID: 36113401
[TBL] [Abstract][Full Text] [Related]
3. Perspectives on the use of ceftolozane/tazobactam: a review of clinical trial data and real-world evidence.
Martin-Loeches I; Bruno CJ; DeRyke CA
Future Microbiol; 2024; 19(6):465-480. PubMed ID: 38252038
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of PmrA and PmrB genes in colistin-resistant Pseudomonas aeruginosa strains via PCR method.
Heidari L; Sepahvand S; Darvishi M; Jafari R
Pak J Pharm Sci; 2019 May; 32(3 (Supplementary)):1175-1177. PubMed ID: 31303587
[TBL] [Abstract][Full Text] [Related]
5. Which trial do we need? How to treat Pseudomonas aeruginosa bacteraemia-proposal for an umbrella randomized controlled trial.
Gilboa M; van Duin D; Yahav D
Clin Microbiol Infect; 2023 Jul; 29(7):829-831. PubMed ID: 37004748
[No Abstract] [Full Text] [Related]
6. Colistin Enhances Rifampicin's Antimicrobial Action in Colistin-Resistant Pseudomonas aeruginosa Biofilms.
Armengol E; Kragh KN; Tolker-Nielsen T; Sierra JM; Higazy D; Ciofu O; Viñas M; Høiby N
Antimicrob Agents Chemother; 2023 Apr; 67(4):e0164122. PubMed ID: 36856424
[TBL] [Abstract][Full Text] [Related]
7. Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients.
Hachem RY; Chemaly RF; Ahmar CA; Jiang Y; Boktour MR; Rjaili GA; Bodey GP; Raad II
Antimicrob Agents Chemother; 2007 Jun; 51(6):1905-11. PubMed ID: 17387153
[TBL] [Abstract][Full Text] [Related]
8. Colistin plasma concentrations are not associated with better clinical outcomes in patients with pneumonia caused by extremely drug-resistant
Sorlí L; Luque S; Li J; Benítez-Cano A; Fernández X; Prim N; Vega V; Gómez-Junyent J; López-Montesinos I; Gómez-Zorrilla S; Montero MM; Grau S; Horcajada JP
Microbiol Spectr; 2023 Dec; 11(6):e0296723. PubMed ID: 37943035
[TBL] [Abstract][Full Text] [Related]
9. Liposomal Formulation Reduces Transport and Cell Uptake of Colistin in Human Lung Epithelial Calu-3 Cell and 3D Human Lung Primary Tissue Models.
Huang Y; Yu S; Ahmed MU; Zhou QT
AAPS PharmSciTech; 2024 Feb; 25(3):40. PubMed ID: 38366100
[TBL] [Abstract][Full Text] [Related]
10. Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumonia.
Gregorova M; Morse D; Brignoli T; Steventon J; Hamilton F; Albur M; Arnold D; Thomas M; Halliday A; Baum H; Rice C; Avison MB; Davidson AD; Santopaolo M; Oliver E; Goenka A; Finn A; Wooldridge L; Amulic B; Boyton RJ; Altmann DM; Butler DK; McMurray C; Stockton J; Nicholls S; Cooper C; Loman N; Cox MJ; Rivino L; Massey RC
Elife; 2020 Dec; 9():. PubMed ID: 33331820
[TBL] [Abstract][Full Text] [Related]
11. Widespread fungal-bacterial competition for magnesium lowers bacterial susceptibility to polymyxin antibiotics.
Hsieh YP; Sun W; Young JM; Cheung R; Hogan DA; Dandekar AA; Malik HS
PLoS Biol; 2024 Jun; 22(6):e3002694. PubMed ID: 38900845
[TBL] [Abstract][Full Text] [Related]
12. Engineered live bacteria suppress Pseudomonas aeruginosa infection in mouse lung and dissolve endotracheal-tube biofilms.
Mazzolini R; Rodríguez-Arce I; Fernández-Barat L; Piñero-Lambea C; Garrido V; Rebollada-Merino A; Motos A; Torres A; Grilló MJ; Serrano L; Lluch-Senar M
Nat Biotechnol; 2023 Aug; 41(8):1089-1098. PubMed ID: 36658340
[TBL] [Abstract][Full Text] [Related]
13. Chronic Purulent Conjunctivitis Associated With Extensively Drug-Resistant Pseudomonas aeruginosa.
Fowler TE; Bloomquist RF; Sakhalkar MV; Bloomquist DT
JAMA Ophthalmol; 2023 Jun; 141(6):609-610. PubMed ID: 37166824
[TBL] [Abstract][Full Text] [Related]
14. Monotherapy or combination antibiotic therapy in the treatment of Pseudomonas aeruginosa ventilator-associated pneumonia.
Shen Y; Xie X
Crit Care; 2023 Sep; 27(1):364. PubMed ID: 37737175
[No Abstract] [Full Text] [Related]
15. A link between pH homeostasis and colistin resistance in bacteria.
Panta PR; Doerrler WT
Sci Rep; 2021 Jun; 11(1):13230. PubMed ID: 34168215
[TBL] [Abstract][Full Text] [Related]
16. Authors response: "Nebulized colistin as the adjunctive treatment for ventilator-associated pneumonia: A systematic review and meta-analysis".
Zhang X; Cui X; Jiang M; Huang S; Yang M
J Crit Care; 2024 Feb; 79():154467. PubMed ID: 37977920
[No Abstract] [Full Text] [Related]
17. Use of ceftolozane/tazobactam as salvage therapy for infections due to extensively drug-resistant Pseudomonas aeruginosa.
Dinh A; Wyplosz B; Kernéis S; Lebeaux D; Bouchand F; Duran C; Béraud G; Lazaro P; Davido B; Hénard S; Canouï E; Ferry T; Wolff M
Int J Antimicrob Agents; 2017 Jun; 49(6):782-783. PubMed ID: 28412272
[No Abstract] [Full Text] [Related]
18. Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: Clinical Effectiveness and Evolution of Resistance.
Haidar G; Philips NJ; Shields RK; Snyder D; Cheng S; Potoski BA; Doi Y; Hao B; Press EG; Cooper VS; Clancy CJ; Nguyen MH
Clin Infect Dis; 2017 Jul; 65(1):110-120. PubMed ID: 29017262
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of post-surgical osteomyelitis caused by XDR Pseudomonas aeruginosa with ceftolozane/tazobactam monotherapy.
Gentile I; Buonomo AR; Maraolo AE; Scotto R; De Zottis F; Di Renzo G; Borgia G
J Antimicrob Chemother; 2017 Sep; 72(9):2678-2679. PubMed ID: 28575437
[No Abstract] [Full Text] [Related]
20. Multidrug Resistant
Aye C; Williams M; Horvath R
Case Rep Infect Dis; 2017; 2017():1402320. PubMed ID: 28386491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
